FoxO1 regulates allergic asthmatic inflammation through regulating polarization of the macrophage inflammatory phenotype

Oncotarget

Volumn 7, Issue 14, 2016, Pages 17532-17546

  Chung, Sangwoon ^a   Lee, Tae Jin ^b   Reader, Brenda F ^a   Kim, Ji Young ^a   Lee, Yong Gyu ^a   Park, Gye Young ^c   Karpurapu, Manjula ^a   Ballinger, Megan N ^a   Qian, Feng ^a   Rusu, Luiza ^a   Chung, Hae Young ^d   Unterman, Terry G ^e   Croce, Carlo M ^b   Christman, John W ^a  

^a OHIO STATE UNIVERSITY   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d Pusan National University   (South Korea)

^e UNIVERSITY OF ILLINOIS   (United States)

Author keywords

Asthma; Eosinophilic lung inflammation; FoxO1; Immune response; Immunity; Immunology and Microbiology Section; M2 macrophage phenotype

Indexed keywords

ANTIASTHMATIC AGENT; AS 1842856; BACTERIAL ANTIGEN; GAMMA INTERFERON; HOUSE DUST ALLERGEN; INTERFERON REGULATORY FACTOR 4; INTERLEUKIN 4; RAGWEED ANTIGEN; TRANSCRIPTION FACTOR FKHR; UNCLASSIFIED DRUG; FOXO1 PROTEIN, MOUSE; INTERFERON REGULATORY FACTOR; INTERFERON REGULATORY FACTOR-4;

ALLERGIC ASTHMA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG MECHANISM; FOXO1 GENE; GENE CONTROL; GENE DELETION; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE OVEREXPRESSION; IMMUNE RESPONSE; IN VITRO STUDY; IRF4 GENE; LUNG ALVEOLUS MACROPHAGE; MACROPHAGE ACTIVATION; MACROPHAGE FUNCTION; MACROPHAGE POLARIZATION; MOUSE; NONHUMAN; PHENOTYPE; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROVOCATION TEST; SIGNAL TRANSDUCTION; UPREGULATION; ANIMAL; ASTHMA; CELL POLARITY; IMMUNOLOGY; INFLAMMATION; KNOCKOUT MOUSE;

ANIMALS; ASTHMA; CELL POLARITY; FORKHEAD BOX PROTEIN O1; INFLAMMATION; INTERFERON REGULATORY FACTORS; MACROPHAGES, ALVEOLAR; MICE; MICE, KNOCKOUT; PHENOTYPE;

EID: 84975513583     PISSN: None     EISSN: 19492553     Source Type: Journal    
DOI: 10.18632/oncotarget.8162     Document Type: Article

References (74)

1. Fanta CH. Asthma. N Engl J Med. 2009; 360:1002-1014.
2. Holtzman MJ. Asthma as a chronic disease of the innate and adaptive immune systems responding to viruses and allergens. J Clin Invest. 2012; 122:2741-2748.
3. Wenzel SE. Asthma phenotypes: the evolution from clinical to molecular approaches. Nat Med. 2012; 18:716-725.
4. Al-Muhsen S, Johnson JR and Hamid Q. Remodeling in asthma. J Allergy Clin Immunol. 2011; 128:451-462; quiz 463-454.
5. Kiss M, Czimmerer Z and Nagy L. The role of lipidactivated nuclear receptors in shaping macrophage and dendritic cell function: From physiology to pathology. J Allergy Clin Immunol. 2013; 132:264-286.
6. Moreira AP and Hogaboam CM. Macrophages in allergic asthma: fine-tuning their pro-and anti-inflammatory actions for disease resolution. J Interferon Cytokine Res. 2011; 31:485-491.
7. Wynn TA. Type 2 cytokines: mechanisms and therapeutic strategies. Nat Rev Immunol. 2015; 15:271-282.
8. Park GY, Lee YG, Berdyshev E, Nyenhuis S, Du J, Fu P, Gorshkova IA, Li Y, Chung S, Karpurapu M, Deng J, Ranjan R, Xiao L, Jaffe HA, Corbridge SJ, Kelly EA, et al. Autotaxin production of lysophosphatidic acid mediates allergic asthmatic inflammation. Am J Respir Crit Care Med. 2013; 188:928-940.
9. Lee YG, Jeong JJ, Nyenhuis S, Berdyshev E, Chung S, Ranjan R, Karpurapu M, Deng J, Qian F, Kelly EA, Jarjour NN, Ackerman SJ, Natarajan V, Christman JW and Park GY. Recruited Alveolar Macrophages, in Response to Airway Epithelial-Derived Monocyte Chemoattractant Protein 1/CCL2, Regulate Airway Inflammation and Remodeling in Allergic Asthma. Am J Respir Cell Mol Biol. 2015; 52:772-784.
10. Wynn TA, Chawla A and Pollard JW. Macrophage biology in development, homeostasis and disease. Nature. 2013; 496:445-455.
11. Chensue SW, Warmington KS, Ruth JH, Sanghi PS, Lincoln P and Kunkel SL. Role of monocyte chemoattractant protein-1 (MCP-1) in Th1 (mycobacterial) and Th2 (schistosomal) antigen-induced granuloma formation: relationship to local inflammation, Th cell expression, and IL-12 production. J Immunol. 1996; 157:4602-4608.
12. Gu L, Tseng S, Horner RM, Tam C, Loda M and Rollins BJ. Control of TH2 polarization by the chemokine monocyte chemoattractant protein-1. Nature. 2000; 404:407-411.
13. Julia V, Hessel EM, Malherbe L, Glaichenhaus N, O'Garra A and Coffman RL. A restricted subset of dendritic cells captures airborne antigens and remains able to activate specific T cells long after antigen exposure. Immunity. 2002; 16:271-283.
14. Balhara J and Gounni AS. The alveolar macrophages in asthma: a double-edged sword. Mucosal Immunol. 2012; 5:605-609.
15. Hussell T and Bell TJ. Alveolar macrophages: plasticity in a tissue-specific context. Nat Rev Immunol. 2014; 14:81-93.
16. Nahrendorf M and Swirski FK. Monocyte and macrophage heterogeneity in the heart. Circ Res. 2013; 112:1624-1633.
17. Cassol E, Cassetta L, Rizzi C, Alfano M and Poli G. M1 and M2a polarization of human monocyte-derived macrophages inhibits HIV-1 replication by distinct mechanisms. J Immunol. 2009; 182:6237-6246.
18. Martinez FO and Gordon S. The M1 and M2 paradigm of macrophage activation: time for reassessment. F1000Prime Rep. 2014; 6:13.
19. Moon KA, Kim SY, Kim TB, Yun ES, Park CS, Cho YS, Moon HB and Lee KY. Allergen-induced CD11b+ CD11c(int) CCR3+ macrophages in the lung promote eosinophilic airway inflammation in a mouse asthma model. Int Immunol. 2007; 19:1371-1381.
20. Mautino G, Henriquet C, Gougat C, Le Cam A, Dayer JM, Bousquet J and Capony F. Increased expression of tissue inhibitor of metalloproteinase-1 and loss of correlation with matrix metalloproteinase-9 by macrophages in asthma. Lab Invest. 1999; 79:39-47.
21. Karpurapu M, Wang X, Deng J, Park H, Xiao L, Sadikot RT, Frey RS, Maus UA, Park GY, Scott EW and Christman JW. Functional PU.1 in macrophages has a pivotal role in NF-kappaB activation and neutrophilic lung inflammation during endotoxemia. Blood. 2011; 118:5255-5266.
22. Qian F, Deng J, Lee YG, Zhu J, Karpurapu M, Chung S, Zheng JN, Xiao L, Park GY and Christman JW. The transcription factor PU.1 promotes alternative macrophage polarization and asthmatic airway inflammation. J Mol Cell Biol. 2015; 7:557-567.
23. Satoh T, Takeuchi O, Vandenbon A, Yasuda K, Tanaka Y, Kumagai Y, Miyake T, Matsushita K, Okazaki T, Saitoh T, Honma K, Matsuyama T, Yui K, Tsujimura T, Standley DM, Nakanishi K, et al. The Jmjd3-Irf4 axis regulates M2 macrophage polarization and host responses against helminth infection. Nat Immunol. 2010; 11:936-944.
24. Nelson SM, Lei X and Prabhu KS. Selenium levels affect the IL-4-induced expression of alternative activation markers in murine macrophages. J Nutr. 2011; 141:1754-1761.
25. Liao X, Sharma N, Kapadia F, Zhou G, Lu Y, Hong H, Paruchuri K, Mahabeleshwar GH, Dalmas E, Venteclef N, Flask CA, Kim J, Doreian BW, Lu KQ, Kaestner KH, Hamik A, et al. Kruppel-like factor 4 regulates macrophage polarization. J Clin Invest. 2011; 121:2736-2749.
26. Dejean AS, Hedrick SM and Kerdiles YM. Highly specialized role of Forkhead box O transcription factors in the immune system. Antioxid Redox Signal. 2011; 14:663-674.
27. Savai R, Al-Tamari HM, Sedding D, Kojonazarov B, Muecke C, Teske R, Capecchi MR, Weissmann N, Grimminger F, Seeger W, Schermuly RT and Pullamsetti SS. Pro-proliferative and inflammatory signaling converge on FoxO1 transcription factor in pulmonary hypertension. Nat Med. 2014; 20:1289-1300.
28. I OS, Zhang W, Wasserman DH, Liew CW, Liu J, Paik J, DePinho RA, Stolz DB, Kahn CR, Schwartz MW and Unterman TG. FoxO1 integrates direct and indirect effects of insulin on hepatic glucose production and glucose utilization. Nat Commun. 2015; 6:7079.
29. Chung S, Ranjan R, Lee YG, Park GY, Karpurapu M, Deng J, Xiao L, Kim JY, Unterman TG and Christman JW. Distinct role of FoxO1 in M-CSF-and GM-CSFdifferentiated macrophages contributes LPS-mediated IL-10: implication in hyperglycemia. J Leukoc Biol. 2015.
30. Brunet A, Bonni A, Zigmond MJ, Lin MZ, Juo P, Hu LS, Anderson MJ, Arden KC, Blenis J and Greenberg ME. Akt promotes cell survival by phosphorylating and inhibiting a Forkhead transcription factor. Cell. 1999; 96:857-868.
31. Eguchi J, Wang X, Yu S, Kershaw EE, Chiu PC, Dushay J, Estall JL, Klein U, Maratos-Flier E and Rosen ED. Transcriptional control of adipose lipid handling by IRF4. Cell Metab. 2011; 13:249-259.
32. Vasquez YM, Mazur EC, Li X, Kommagani R, Jiang L, Chen R, Lanz RB, Kovanci E, Gibbons WE and DeMayo FJ. FOXO1 is required for binding of PR on IRF4, novel transcriptional regulator of endometrial stromal decidualization. Mol Endocrinol. 2015; 29:421-433.
33. Goplen N, Karim MZ, Liang Q, Gorska MM, Rozario S, Guo L and Alam R. Combined sensitization of mice to extracts of dust mite, ragweed, and Aspergillus species breaks through tolerance and establishes chronic features of asthma. J Allergy Clin Immunol. 2009; 123:925-932 e911.
34. Gueders MM, Paulissen G, Crahay C, Quesada-Calvo F, Hacha J, Van Hove C, Tournoy K, Louis R, Foidart JM, Noel A and Cataldo DD. Mouse models of asthma: a comparison between C57BL/6 and BALB/c strains regarding bronchial responsiveness, inflammation, and cytokine production. Inflamm Res. 2009; 58:845-854.
35. Li P, Zhao Y, Wu X, Xia M, Fang M, Iwasaki Y, Sha J, Chen Q, Xu Y and Shen A. Interferon gamma (IFN-gamma) disrupts energy expenditure and metabolic homeostasis by suppressing SIRT1 transcription. Nucleic Acids Res. 2011; 40:1609-1620.
36. Nagashima T, Shigematsu N, Maruki R, Urano Y, Tanaka H, Shimaya A, Shimokawa T and Shibasaki M. Discovery of novel forkhead box O1 inhibitors for treating type 2 diabetes: improvement of fasting glycemia in diabetic db/db mice. Mol Pharmacol. 2010; 78:961-970.
37. Busslinger M. Transcriptional control of early B cell development. Annu Rev Immunol. 2004; 22:55-79.
38. Lohoff M, Mittrucker HW, Prechtl S, Bischof S, Sommer F, Kock S, Ferrick DA, Duncan GS, Gessner A and Mak TW. Dysregulated T helper cell differentiation in the absence of interferon regulatory factor 4. Proc Natl Acad Sci U S A. 2002; 99:11808-11812.
39. Tailor P, Tamura T and Ozato K. IRF family proteins and type I interferon induction in dendritic cells. Cell Res. 2006; 16:134-140.
40. Iskandar K, Cao Y, Hayashi Y, Nakata M, Takano E, Yada T, Zhang C, Ogawa W, Oki M, Chua S, Jr., Itoh H, Noda T, Kasuga M and Nakae J. PDK-1/FoxO1 pathway in POMC neurons regulates Pomc expression and food intake. Am J Physiol Endocrinol Metab. 2010; 298:E787-798.
41. Lane SJ, Sousa AR and Lee TH. The role of the macrophage in asthma. Allergy. 1994; 49:201-209.
42. Medoff BD, Okamoto Y, Leyton P, Weng M, Sandall BP, Raher MJ, Kihara S, Bloch KD, Libby P and Luster AD. Adiponectin deficiency increases allergic airway inflammation and pulmonary vascular remodeling. Am J Respir Cell Mol Biol. 2009; 41:397-406.
43. Byrne AJ, Mathie SA, Gregory LG and Lloyd CM. Pulmonary macrophages: key players in the innate defence of the airways. Thorax. 2015; 70:1189-1196.
44. Qian F, Deng J, Lee YG, Zhu J, Karpurapu M, Chung S, Zheng JN, Xiao L, Park GY and Christman JW. The transcription factor PU.1 promotes alternative macrophage polarization and asthmatic airway inflammation. J Mol Cell Biol. 2015.
45. Careau E and Bissonnette EY. Adoptive transfer of alveolar macrophages abrogates bronchial hyperresponsiveness. Am J Respir Cell Mol Biol. 2004; 31:22-27.
46. Mathie SA, Dixon KL, Walker SA, Tyrrell V, Mondhe M, O'Donnell VB, Gregory LG and Lloyd CM. Alveolar macrophages are sentinels of murine pulmonary homeostasis following inhaled antigen challenge. Allergy. 2015; 70:80-89.
47. Stein M, Keshav S, Harris N and Gordon S. Interleukin 4 potently enhances murine macrophage mannose receptor activity: a marker of alternative immunologic macrophage activation. J Exp Med. 1992; 176:287-292.
48. Song C, Luo L, Lei Z, Li B, Liang Z, Liu G, Li D, Zhang G, Huang B and Feng ZH. IL-17-producing alveolar macrophages mediate allergic lung inflammation related to asthma. J Immunol. 2008; 181:6117-6124.
49. Yang M, Kumar RK and Foster PS. Interferon-gamma and pulmonary macrophages contribute to the mechanisms underlying prolonged airway hyperresponsiveness. Clin Exp Allergy. 2010; 40:163-173.
50. Wang Y, Zhou Y and Graves DT. FOXO transcription factors: their clinical significance and regulation. Biomed Res Int. 2014; 2014:925350.
51. Fan W, Morinaga H, Kim JJ, Bae E, Spann NJ, Heinz S, Glass CK and Olefsky JM. FoxO1 regulates Tlr4 inflammatory pathway signalling in macrophages. EMBO J. 2010; 29:4223-4236.
52. Su D, Coudriet GM, Hyun Kim D, Lu Y, Perdomo G, Qu S, Slusher S, Tse HM, Piganelli J, Giannoukakis N, Zhang J and Dong HH. FoxO1 links insulin resistance to proinflammatory cytokine IL-1beta production in macrophages. Diabetes. 2009; 58:2624-2633.
53. Seiler F, Hellberg J, Lepper PM, Kamyschnikow A, Herr C, Bischoff M, Langer F, Schafers HJ, Lammert F, Menger MD, Bals R and Beisswenger C. FOXO transcription factors regulate innate immune mechanisms in respiratory epithelial cells. J Immunol. 2013; 190:1603-1613.
54. Brown J, Wang H, Suttles J, Graves DT and Martin M. Mammalian target of rapamycin complex 2 (mTORC2) negatively regulates Toll-like receptor 4-mediated inflammatory response via FoxO1. J Biol Chem. 2011; 286:44295-44305.
55. Eguchi J, Kong X, Tenta M, Wang X, Kang S and Rosen ED. Interferon regulatory factor 4 regulates obesityinduced inflammation through regulation of adipose tissue macrophage polarization. Diabetes. 2013; 62:3394-3403.
56. Bruchard M, Rebe C, Derangere V, Togbe D, Ryffel B, Boidot R, Humblin E, Hamman A, Chalmin F, Berger H, Chevriaux A, Limagne E, Apetoh L, Vegran F and Ghiringhelli F. The receptor NLRP3 is a transcriptional regulator of TH2 differentiation. Nat Immunol. 2015; 16:859-870.
57. Singer BD and D'Alessio FR. Regulatory T cell Itch reins in Th2 inflammation. Cell Mol Immunol. 2014; 11:126-128.
58. Williams JW, Tjota MY, Clay BS, Vander Lugt B, Bandukwala HS, Hrusch CL, Decker DC, Blaine KM, Fixsen BR, Singh H, Sciammas R and Sperling AI. Transcription factor IRF4 drives dendritic cells to promote Th2 differentiation. Nat Commun. 2013; 4:2990.
59. Schlitzer A, McGovern N, Teo P, Zelante T, Atarashi K, Low D, Ho AW, See P, Shin A, Wasan PS, Hoeffel G, Malleret B, Heiseke A, Chew S, Jardine L, Purvis HA, et al. IRF4 transcription factor-dependent CD11b+ dendritic cells in human and mouse control mucosal IL-17 cytokine responses. Immunity. 2013; 38:970-983.
60. Persson EK, Uronen-Hansson H, Semmrich M, Rivollier A, Hagerbrand K, Marsal J, Gudjonsson S, Hakansson U, Reizis B, Kotarsky K and Agace WW. IRF4 transcriptionfactor-dependent CD103(+)CD11b(+) dendritic cells drive mucosal T helper 17 cell differentiation. Immunity. 2013; 38:958-969.
61. Gao Y, Nish SA, Jiang R, Hou L, Licona-Limon P, Weinstein JS, Zhao H and Medzhitov R. Control of T helper 2 responses by transcription factor IRF4-dependent dendritic cells. Immunity. 2013; 39:722-732.
62. Manni M, Gupta S, Nixon BG, Weaver CT, Jessberger R and Pernis AB. IRF4-Dependent and IRF4-Independent Pathways Contribute to DC Dysfunction in Lupus. PLoS One. 2015; 10:e0141927.
63. Vander Lugt B, Khan AA, Hackney JA, Agrawal S, Lesch J, Zhou M, Lee WP, Park S, Xu M, DeVoss J, Spooner CJ, Chalouni C, Delamarre L, Mellman I and Singh H. Transcriptional programming of dendritic cells for enhanced MHC class II antigen presentation. Nat Immunol. 2014; 15:161-167.
64. Bedoret D, Wallemacq H, Marichal T, Desmet C, Quesada Calvo F, Henry E, Closset R, Dewals B, Thielen C, Gustin P, de Leval L, Van Rooijen N, Le Moine A, Vanderplasschen A, Cataldo D, Drion PV, et al. Lung interstitial macrophages alter dendritic cell functions to prevent airway allergy in mice. J Clin Invest. 2009; 119:3723-3738.
65. Bang BR, Chun E, Shim EJ, Lee HS, Lee SY, Cho SH, Min KU, Kim YY and Park HW. Alveolar macrophages modulate allergic inflammation in a murine model of asthma. Exp Mol Med. 2011; 43:275-280.
66. Nair MG, Du Y, Perrigoue JG, Zaph C, Taylor JJ, Goldschmidt M, Swain GP, Yancopoulos GD, Valenzuela DM, Murphy A, Karow M, Stevens S, Pearce EJ and Artis D. Alternatively activated macrophage-derived RELM-(alpha) is a negative regulator of type 2 inflammation in the lung. J Exp Med. 2009; 206:937-952.
67. Tsuchiya K, Westerterp M, Murphy AJ, Subramanian V, Ferrante AW, Jr., Tall AR and Accili D. Expanded granulocyte/monocyte compartment in myeloid-specific triple FoxO knockout increases oxidative stress and accelerates atherosclerosis in mice. Circ Res. 2013; 112:992-1003.
68. Tsuchiya K, Tanaka J, Shuiqing Y, Welch CL, DePinho RA, Tabas I, Tall AR, Goldberg IJ and Accili D. FoxOs integrate pleiotropic actions of insulin in vascular endothelium to protect mice from atherosclerosis. Cell Metab. 2012; 15:372-381.
69. Naini SM, Choukroun GJ, Ryan JR, Hentschel DM, Shah JV and Bonventre JV. Cytosolic phospholipase A2alpha regulates G1 progression through modulating FOXO1 activity. FASEB J. 2015.
70. Shen Y, Xu W, You H, Su D, Xing J, Li M, Li L and Liang X. FoxO1 inhibits transcription and membrane trafficking of epithelial Na+ channel. J Cell Sci. 2015; 128:3621-3630.
71. Deng L, Huang L, Sun Y, Heath JM, Wu H and Chen Y. Inhibition of FOXO1/3 promotes vascular calcification. Arterioscler Thromb Vasc Biol. 2015; 35:175-183.
72. Chung S, Sundar IK, Hwang JW, Yull FE, Blackwell TS, Kinnula VL, Bulger M, Yao H and Rahman I. NF-kappaB inducing kinase, NIK mediates cigarette smoke/TNFalphainduced histone acetylation and inflammation through differential activation of IKKs. PLoS One. 2011; 6:e23488.
73. Sun Z, Miller RA, Patel RT, Chen J, Dhir R, Wang H, Zhang D, Graham MJ, Unterman TG, Shulman GI, Sztalryd C, Bennett MJ, Ahima RS, Birnbaum MJ and Lazar MA. Hepatic Hdac3 promotes gluconeogenesis by repressing lipid synthesis and sequestration. Nat Med. 2012; 18:934-942.
74. Shin DJ and Osborne TF. FGF15/FGFR4 integrates growth factor signaling with hepatic bile acid metabolism and insulin action. J Biol Chem. 2009; 284:11110-11120.